Healix

News & Events

Filter
All Categories
News
Events

American College of Rheumatology (ACR) Annual Meeting

Meet the Healix team on November 10-12, 2019, at the American College of Rheumatology Annual Meeting in Atlanta, GA.

Read More

American College of Allergy, Asthma, & Immunology (ACAAI) Annual Meeting

Meet the Healix team in Houston, November 7-11, 2019, to learn about how we help practices like yours to provide unparalleled infusion patient care. 

Read More

American College of Gastroenterology (ACG) Annual Meeting

Join Healix at the 2019 American College of Gastroenterology (ACG) Annual Meeting October 25-28, 2019.

Read More

CHEST Annual Meeting

Our team is excited to attend the 2019 CHEST conference in New Orleans, LA, October 21-23, 2019.

Read More

IDWeek

Visit our team at IDWeek October 2 – 6, 2019, in Washington D.C. to learn how we can help infectious disease practices like yours to provide unparalleled infusion patient care.

Read More

Rheumatology Association of Minnesota and Dakotas (RA-MD)

Join Healix in Bloomington, MN on September 28, 2019, for the Rheumatology Association of Minnesota and Dakotas (RA-MD) Annual Meeting.

Read More

Congress of Clinical Rheumatology (CCR) Symposium

Visit the Healix team at the Congress of Clinical Rheumatology (CCR) Symposium on September 26 – 29, 2019 in San Diego, CA.

Read More

Illinois State Neurological Society (ISNS) Annual Meeting

Meet the Healix team September 21, 2019, at the Illinois State Neurological Society (ISNS) Annual Meeting in Chicago, IL.

Read More

Virginia Society of Rheumatologists 32nd Annual Scientific Meeting

Healix will be attending and exhibiting at the 2019 Virginia Society of Rheumatologists 32nd Annual Scientific Meeting on September 20- 22, 2019, in Alexandria, VA.

Read More

12th Annual Perspectives in Rheumatic Diseases Annual Meeting

Join Healix in Las Vegas, NV on September 20 – 21, 2019, for the 12th Annual Perspectives in Rheumatic Diseases Annual Meeting.

Read More

Florida Society of Neurology (FSN) Annual Meeting

Healix is proudly exhibiting at the upcoming Florida Society of Neurology Annual Meeting on September 13 -15, 2019, in Orlando, FL.

Read More

National Organization of Rheumatology Managers (NORM) Annual Meeting

Meet with the Healix team at the National Organization of Rheumatology Managers (NORM) Conference on September 12 – 14, 2019, in Grand Rapids, MI.

Read More

Rheumatology Society of New Mexico (RSNM) Annual Meeting

Healix will be exhibiting at the Rheumatology Society of New Mexico on September 7, 2019, in Albuquerque, NM.

Read More

Missouri Kansas Neurological Society (MKNS) Annual Meeting

Visit with the Healix team at Missouri Kansas Neurological Society Annual Meeting on September 7, 2019, in Branson, MO!

Read More

Long Island Allergy & Asthma Society (LIAAS) Annual Meeting

Join Healix in Montauk, New York, on September 6 – 8, 2019, for the 2019 Long Island Allergy & Asthma Society (LIAAS) Annual Meeting.

Read More

Ohio Association of Rheumatology (OAR) Annual Meeting

Healix is excited to exhibit at the upcoming Ohio Association of Rheumatology Annual Meeting on August 23-24, 2019, in Columbus, OH.

Read More

GI Outlook 2019: The Practice Management Conference

Meet the Healix team August 2-4, at the GI Outlook Conference in Hollywood, CA. Visit booth 21 to discover how working with Healix gives you the advantage!

Read More

Healix Infusion Therapy Selected as Limited Distribution Network Partner for Cutaquig®

Healix Infusion Therapy is pleased to announce that it has been selected as a limited distribution network partner for Cutaquig by Octapharma AG. Cutaquig, Octapharma’s new subcutaneous immune globulin, launches this week.

Read More

Texas Infectious Diseases Society (TIDS) Annual Meeting

Healix will be attending and exhibiting at the Texas Infectious Diseases Society (TIDS) Annual Meeting on June 7-9., 2019, in Lost Pines, Texas. Come and visit with our team to learn about.

Read More

Arizona United Rheumatology Alliance (AURA) Annual Meeting

Join Healix in sunny Sedona, Arizona, on May 31 – June 2, 2019, for the Arizona United Rheumatology Alliance (AURA) Annual Meeting. Our team would love to meet with you to discuss how.

Read More

Georgia Society of Rheumatology (GSR) Annual Meeting

Healix is proudly exhibiting at the upcoming Georgia Society of Rheumatology (GSR) Annual Meeting on May 31 – June 2, 2019, at the Ritz-Carlton, Reynols Plantation, in Greensboro, Georgia. If you are.

Read More

Consortium of Multiple Sclerosis Centers (CMSC) Annual Meeting

Are you attending the Consortium of Multiple Sclerosis Centers (CMSC) Annual Meeting on May 28 – June 1 in Seattle, Washington? Come visit the Healix booth to discuss our expert infusion management.

Read More

Digestive Disease Week (DDW)

Come and visit with the Healix team at Digestive Disease Week (DDW) on May 19-21, 2019, in San Diego! We would love to meet with you to discuss how a Healix-managed.

Read More

American Academy of Neurology (AAN) Annual Meeting

Join Healix at the 2019 American Academy of Neurology (AAN) Annual Meeting on May 4-8, 2019, in Philadelphia, Pennsylvania. Our team of Healix representatives will be available at our booth.

Read More

Healix Selects Citus Health to Digitally Transform Communication Streams and Care Coordination

Healix, the nation’s leader in providing physician office-based infusion services, will implement the Citus Health digital solution suite to streamline multi-office healthcare communications and automate documentation workflows to provide.

Read More

Healix Announces Strategic Partnership with WeInfuse

SUGAR LAND, TX (December 6, 2018) – Healix, the nation’s leader in providing physician office-based infusion services, announces a strategic partnership with WeInfuse, the first and only end-to-end workflow.

Read More

Healix Announces Strategic Partnership with DoseMe for Precision Dosing

SUGAR LAND, TX (July 20, 2018) – Healix, the nation’s leader in physician office based infusion services, announced a strategic relationship with DoseMe, a precision dosing decision support platform specifically.

Read More

TA Associates Announces Investment in Healix

BOSTON and SUGAR LAND, Texas, December 18, 2017 – TA Associates, a leading global growth private equity firm, today announced that it has completed a strategic growth investment in Healix, a provider of outsourced.

Read More

Healix Relocates to New State-of-the-Art Pharmacy Facility in Sugar Land, Texas

UGAR LAND, TX (July 28, 2017) – Healix Infusion Therapy, Inc. is proud to announce the relocation of its pharmacy operation to a new, state-of-the-art facility in Sugar Land, Texas. With more than 28.

Read More

Healix is Now a National Provider of Trogarzo™ (ibalizumab-uiyk)

SUGAR LAND, TX (July 28, 2017) – Healix® is Now a National Provider of Trogarzo™ (ibalizumab-uiyk). Trogarzo™ is a new humanized monoclonal antibody for the treatment of multidrug-resistant (MDR) HIV-1.

Read More

Outpatient Treatment of Osteomyelitis with Telavancin

SUGAR LAND, TX (July 14, 2017) – Gram-positive osteomyelitis was successfully treated with telavancin, as published in an article in The International Journal of Antimicrobial Agents.

Read More

Healix® is Now a National Provider of Cuvitru® [Immune Globulin Subcutaneous (Human)] 20%

SUGAR LAND, TX (March 20, 2017) – Healix has been selected among an exclusive number of distributers to become a national provider of Cuvitru [Immune Globulin Subcutaneous (Human)] 20%. Immunologists who partner with Healix.

Read More

Dalbavancin: A Nationwide Outpatient Experience in Physician Office Infusion Centers

SUGAR LAND, TX (May 23, 2016) – Dalbavancin is a long-acting lipoglycopeptide, approved for the treatment of acute bacterial skin and skin structure infections caused by susceptible gram-positive bacteria. A retrospective study was.

Read More

Antimicrobial Regimen and Safety of Pediatric Outpatient Treatment in a POIC

SUGAR LAND, TX (January 25, 2016) – Pediatric outpatient antimicrobial therapy (OPAT) is increasing, however, data on management, safety, and clinical outcomes are limited. A two-year retrospective, observational study was conducted of 64 pediatric.

Read More

A 2-Year Analysis of 30-Day Hospital Readmissions and Cost Benefits of Septicemia OPAT in a POIC

SAN DIEGO, CA (October 10, 2015) – Septicemia constitutes a major cause for 30-day hospital readmissions and is the most expensive condition treated in U.S. hospitals according to the Agency for Healthcare.

Read More

Low Hospital Admission Rates Following POIC-Based Outpatient Treatment with Intravenous Antibiotics

PHILADELPHIA, PA (October 10, 2014) – Outpatient antimicrobial therapy (OPAT) provided by a physician office infusion center revealed an overall low 30-day hospital admission rate of 6.8% compared to 26% previously reported. This collaborative, retrospective study.

Read More

Comparison of Outpatient Antimicrobial Therapy (OPAT) in a POIC vs. Traditional Home Health Care

PHILADELPHIA, PA (October 10, 2014) – Outpatient antimicrobial therapy (OPAT) in a physician office infusion center showed improved quality of care in contrast to a traditional home health care setting. A collaborative, retrospective study.

Read More

Clinical Success in Outpatient Treatment of Complicated Urinary Tract Infections with Ertapenem

SAN FRANCISCO, CA (October 4, 2013) – A retrospective database review was conducted of patients aged 18 and older receiving ertapenem therapy for UTI between July 1, 2010, and December 31, 2013. Seventy-five patients with a UTI diagnosis.

Read More

Clinical & Economic Outcomes of Outpatient Parenteral Antimicrobial Therapy among Indigent Patients

SAN FRANCISCO, CA (October 4, 2013) – This study is a report of clinical and economic outcome data of a hospital-funded Indigent Healthcare Program conducted in 11 Infectious Disease (ID) Physician Office Infusion Centers (POICs).

Read More

Outpatient Parenteral Antimicrobial Therapy for Treatment of Complicated Intra-Abdominal Infections

SAN FRANCISCO, CA (October 4, 2013) – A multi-center retrospective review of 120 patients receiving intravenous antibiotics (IVAB) for complicated intra-abdominal infections (IAI) in a physician office infusion center (POIC) was conducted to determine the.

Read More

Outpatient Parenteral Antimicrobial Therapy for Treatment of Complicated Intra-Abdominal Infections

SAN FRANCISCO, CA (October 9, 2013) – A multi-center review of 100 patients receiving Vancomycin was conducted to determine the effectiveness of patient monitoring and the recognition of adverse events in an outpatient setting.

Read More

Successful Treatment of Polymicrobial Calcaneal Osteomyelitis

SUGAR LAND, TX – Multidrug-resistant osteomyelitis was successfully treated with telavancin, rifampin, and meropenem, as published in an article in The Annals of Pharmacotherapy. Primary author was Mary Beth Brinkman.

Read More

C. difficile-Associated Diarrhea Incidence & Outcomes in Physician Office Infusion Centers

SAN DIEGO, CA (October 19, 2012) – A retrospective review of 1,352 patients treated at nine Infectious Disease POICs with intravenous antibiotics (IVAB) from January 1 to June 30, 2011, was conducted to assess the reduced risk level.

Read More

Cost & Outcomes Comparison of Patients Whose Treatment Began in Infusion Center vs. After Discharge

SAN DIEGO, CA (October 19, 2012) – A retrospective, multicenter review was conducted of eligible patients treated in the POIC from January 1- June 30, 2011, including 30-day follow-up to compare outcomes and costs in.

Read More

Outcomes Comparison of IV Antimicrobials in an Office Infusion Center vs. Home Care Services

SAN DIEGO, CA (October 19, 2012) – A retrospective review was conducted of randomly selected records for patients treated in four Infectious Disease POICs from January 2010-December 2011, to compare patient management and outcomes in.

Read More

Utilization of IV Antimicrobials Over a One-Year Period in Physician Office Infusion Centers

SAN DIEGO, CA (October 19, 2012) – A multi-center retrospective review of 11,616 patients receiving intravenous antimicrobials (IVAM) was conducted to determine utilization of IVAM in POICs and efficient device utilization. In the 65 participating.

Read More

Successful, Cost-Saving Outpatient Parenteral Antimicrobial Therapy Following Hospital Discharge

SAN DIEGO, CA (October 19, 2012) – A retrospective pilot study was conducted of all patients, from January 2011 through April 2012, receiving OPAT under an indigent healthcare program (a hospital-funded program providing IV antibiotics through.

Read More

Low Rates of C. difficile Associated Diarrhea in Patients Receiving IVAB in the Outpatient Setting

BOSTON, MA (October 21, 2011) – Patients receiving intravenous antibiotics in seven Infectious Disease Physician Office Infusion Centers (POICs) experienced a low rate of Clostridium difficile associated diarrhea (2.5 per 10,000 patient days). Of the 934.

Read More

Low Readmission and Recurrence Rates of Bacteremia, Endocarditis & Osteomyelitis in Infusion Centers

BOSTON, MA (October 21, 2011) – A multi-center retrospective review of 203 patients treated with long term intravenous antibiotic therapy in physician office infusion centers (POICs) is effective with clinical success rates of 93% in bacteremia, 88%.

Read More

Treatment with IV Antibiotics in an Outpatient POIC Shows Successful Outcomes and Cost Savings

BOSTON, MA (October 21, 2011) – A 3-year trend analysis was conducted of patients initiated on intravenous antibiotics (IVAB) in an Infectious Disease Physician Office Infusion Center (POIC) during the years 2008 – 2010 for.

Read More

Telavancin Treatment in the Outpatient Setting is Effective

BOSTON, MA (October 21, 2011) – In a 16 month period, 47 patients were treated with telavancin in 15 physician office infusion centers (POICs) with indications for acute bacterial skin and skin structure infections (24), osteomyelitis (19), sepsis (3).

Read More

Healix Launches New App to Boost Client Efficiency

SUGAR LAND, TX (January 1, 2011) – Healix announced the official launch of the iPhone® compatible Healix App, a tool for on-the-go physicians to track formulary options with payer reimbursement data.

Read More

How can we help you?

Get in touch with us or explore our offerings.

"Establishing a relationship with Healix has allowed us to provide our patients with outstanding care while being able to control the clinical situation and achieve the best possible outcomes."

Andrew Krinsky, MD

Infectious Diseases Associates, Sarasota, Florida

Healix Testimonials
2019-04-10T09:58:14-05:00
Andrew Krinsky, MD

Infectious Diseases Associates, Sarasota, Florida

"Establishing a relationship with Healix has allowed us to provide our patients with outstanding care while being able to control the clinical situation and achieve the best possible outcomes."
“The Healix team has set the bar for professionalism, knowledge of the industry, and customer service that other companies typically fail to meet. Healix has made it a fun, effortless, and significant clinical enhancement for our patients!”

Pam Hamby

Infusion Program Director, The Allergy, Asthma, and Sinus Center Offices in Tennessee, Kentucky, & Georgia

Healix Testimonials
2019-04-11T08:12:34-05:00
Pam Hamby

Infusion Program Director, The Allergy, Asthma, and Sinus Center Offices in Tennessee, Kentucky, & Georgia

“The Healix team has set the bar for professionalism, knowledge of the industry, and customer service that other companies typically fail to meet. Healix has made it a fun, effortless, and significant clinical enhancement for our patients!”
“Our practice has now partnered with Healix for over 15 years to provide in-office infusion services to our patients. Healix had made this process seamless and efficient, resulting in outstanding patient care and many satisfied patients. Their nurses and support staff are well trained and professional and a pleasure to work with. It has added a valuable service line to our practice.”

Timothy Ritter, MD

Texas Digestive Disease Consultants, Dallas, Texas

Healix Testimonials
2019-04-11T08:13:15-05:00
Timothy Ritter, MD

Texas Digestive Disease Consultants, Dallas, Texas

“Our practice has now partnered with Healix for over 15 years to provide in-office infusion services to our patients. Healix had made this process seamless and efficient, resulting in outstanding patient care and many satisfied patients. Their nurses and support staff are well trained and professional and a pleasure to work with. It has added a valuable service line to our practice.”
“The Healix infusion business model works. Our collaborative team of physicians, an infusion nurse, and a clinical pharmacy hotline allows for real-time feedback and course correction if necessary. Healix has turned this small clinic into a real service for the community.”

Philip Blum, MD

MHS Physicians of Texas, Houston, Texas

Healix Testimonials
2019-04-11T08:13:50-05:00
Philip Blum, MD

MHS Physicians of Texas, Houston, Texas

“The Healix infusion business model works. Our collaborative team of physicians, an infusion nurse, and a clinical pharmacy hotline allows for real-time feedback and course correction if necessary. Healix has turned this small clinic into a real service for the community.”
"At Healix we all work together as a team to make it a great place to work for. For the past 10 months, I have really enjoyed working with a talented group of individuals that help one another out. The executive team does a great job of communicating and most importantly listening to all of the feedback employees have! The cohesiveness in teamwork among all of the departments are all reflections of what Healix is all about in achieving the mission and vision of the company. I take pride in working for a prominent company that establishes great relationships on all levels!"

Vanessa Brown

Nursing Department Staffing Manager

Healix Testimonials
2019-06-24T15:03:10-05:00
Vanessa Brown

Nursing Department Staffing Manager

"At Healix we all work together as a team to make it a great place to work for. For the past 10 months, I have really enjoyed working with a talented group of individuals that help one another out. The executive team does a great job of communicating and most importantly listening to all of the feedback employees have! The cohesiveness in teamwork among all of the departments are all reflections of what Healix is all about in achieving the mission and vision of the company. I take pride in working for a prominent company that establishes great relationships on all levels!"
FacebookTwitterLinkedInarrow1arcsearchiconowdtnotfound